Park Square has placed Michael Aldridge as Chief Executive Officer at Focal Medical.
Focal Medical, Inc. (formerly Advanced Chemotherapy Technologies, Inc.), a privately held, biopharmaceutical company developing novel...…
Park Square is pleased to announce the appointment of Tyler Schoen to the position of Director of Finance at OPT Industries. OPT...
Park Square is pleased to announce the placement of Kurt Haggstrom as Chief Commercial Officer at Synchron, an endovascular...
Park Square is pleased to announce the placement of Chris Fuller, Ph.D., as Vice President and Head of Bioinformatics at 64x Bio. 64x Bio...
Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer,
As a free user, you can follow Passle and like posts.
To repost this post to your own Passle blog, you will need to upgrade your account.
For plans and pricing, please contact our sales team at sales@passle.net